Alpha-Synuclein Targeted in Parkinson’s Disease Treatment

This study looks at the protein alpha-synuclein, which is a well-known player in Parkinson’s disease and other related neurological conditions, such as dementia with Lewy bodies. Alpha-synuclein typically resides at presynaptic terminals, the communication hubs of neurons where neurotransmitters are released to other neurons. Reserachers found that groups of the protein, known as multimers, can restrict neurotransmissions. 

READ FULL ARTICLE Curated publisher From Medical News Today